GENE ONLINE|News &
Opinion
Blog

Alnylam Pharmaceuticals
Trials & Approvals RNAi Therapeutics
FDA Approves Alnylam’s Rare Disease RNAi Therapeutic
2022-06-15
COVID-19 Lawsuit
Alnylam Challenges Moderna and Pfizer with Patent Infringement
2022-03-18
Deals siRNA
Novartis Teams Up with Alnylam to Explore Targeted Liver Therapies
2022-01-07
China
Is the Race On for RNAi? A Chinese Pharma’s $450M Deal May Just Be the Start
2021-10-13
COVID-19
Top Announcements from the J.P. Morgan Healthcare Conference 2021
2021-01-13
R&D RNAi Therapeutics
Alnylam Aims to Obtain “Top 5 Biotech” Tag By 2025
2021-01-12
Trials & Approvals RNAi
Alnylam Nears Fourth Approval with Successful Trial Data for RNAi Drug
2021-01-08
Trials & Approvals Liver Enzyme
Alnylam Receives FDA Nod for its Third Rare Disease Drug
2020-11-25
Trials & Approvals CRISPR
Intellia Trials CRISPR Drug as Permanent Cure to Fatal Hereditary Disease
2020-10-21
R&D
Altering the Treatment Landscape of Neurodegenerative Diseases Using Antisense Oligonucleotides (ASOs)
2020-08-17
Trials & Approvals RNAi Therapeutics
Alnylam’s RNAi-Based Therapy Lumasiran Impresses in Phase 3 Primary Hyperoxaluria Trials
2020-06-12
Trials & Approvals Acute Hepatic Porphyria
GIVLAARI to Enter European Market Following EMA Approval
2020-03-04
Manufacturing
JP Morgan Healthcare Conference 2020 Updates
2020-01-16
Manufacturing
The 38th Annual J.P. Morgan Healthcare Conference – What to Expect?
2020-01-13
Trials & Approvals RNAi
FDA approves second RNAi based drug
2019-11-20
LATEST
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
Illumina’s IVD Biomarker Test Becomes the First FDA-approved Pan-cancer Companion Diagnostics Kit
2024-09-11
Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi
2024-09-06
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void
2024-09-05
Breaking New Ground for Clinical Trials with AI/ML Applications
2024-09-05
READ MORE
EVENT
2024-09-13
ESMO Congress 2024
Barcelona, Spain
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-10
BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2024
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top